Full-Time

Quality Systems Engineer

CAPA and Process Improvement

DEKA Research & Development Corp.

DEKA Research & Development Corp.

501-1,000 employees

Independent R&D lab developing medical devices

No salary listed

Manchester, NH, USA

In Person

Bachelor's, Master's

Category
Manufacturing Quality & Test (1)
Required Skills
Word/Pages/Docs
Risk Management
Excel/Numbers/Sheets

Get referred to DEKA Research & Development Corp.

See people who can refer or advise you

Requirements
  • A Bachelor’s or Master’s degree in Engineering, Life Sciences, or a related field.
  • At least 3 years of experience in a quality systems role in a regulated industry, ideally medical devices.
  • Working knowledge of FDA Quality System Regulation (21 CFR Part 820) and ISO 13485.
  • Proficiency with Microsoft Excel, Word, and Visio, or the ability to learn these tools quickly.
  • Strong verbal and written communication skills.
  • Experience in project coordination and technical writing.
Responsibilities
  • Own and manage the end-to-end CAPA process from intake and triage through investigation, root cause analysis, corrective and preventive action planning, and effectiveness verification.
  • Facilitate cross-functional CAPA review meetings and align teams on systemic issues and remediation strategies.
  • Ensure CAPAs have objective evidence, clear problem statements, and traceability to impacted processes, products, or quality records.
  • Maintain CAPA documentation in alignment with regulatory expectations, ensuring timely closure, audit readiness, and linkage to risk management where applicable.
  • Monitor CAPA trends and performance metrics to identify recurring issues and drive continuous improvement.
  • Support training and mentorship of team members on CAPA expectations, best practices, and root cause analysis tools.
  • Own the development and revision of Standard Operating Procedures and associated change controls to support QMS compliance and regulatory alignment.
  • Ensure ongoing compliance with FDA 21 CFR Part 820 and ISO 13485 while maintaining the integrity and effectiveness of the quality management system.
  • Develop working knowledge of DEKA’s QMS processes and use it to identify and implement system improvements.
  • Review and approve quality records for accuracy, completeness, and adherence to applicable requirements.
  • Conduct internal audits and support auditor training to promote audit readiness and regulatory compliance.
  • Support external FDA, ISO, and customer audits by preparing documentation, facilitating audit logistics, and responding to auditor requests in real time.
Desired Qualifications
  • Experience in a regulated industry, ideally medical devices.
DEKA Research & Development Corp.

DEKA Research & Development Corp.

View

DEKA Research & Development Corp. is a leading engineering R&D lab in Manchester, New Hampshire that develops a wide range of practical technologies and devices. It operates by interdisciplinary teams of engineers, machinists, designers, and technicians who take ambitious ideas and turn them into tangible products using advanced design and manufacturing methods. The company differentiates itself through its culture of hands-on experimentation, diverse project portfolio, and a track record of bringing to market or translating ideas into real-world applications. Its goal is to create technologies with a positive, lasting impact on people’s lives by solving meaningful problems.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Manchester, New Hampshire

Founded

1982

Get referred to DEKA Research & Development Corp.

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Diatech acquisition on October 7, 2025 deepened DEKA’s diabetes delivery stack.
  • Emergex collaboration keeps DEKA’s intradermal applicator active across 2026 biotech pipelines.
  • Revelio counted 872 employees in March 2026, and hiring stayed active.

What critics are saying

  • Sequel Med Tech drives twiist commercialization; any 2026 launch miss starves DEKA royalties.
  • Dean Kamen’s February 2026 Epstein scrutiny pressures recruiting, partnerships, and nonprofit ties.
  • DEKA’s revenue depends on a narrow medical-device portfolio; one regulatory failure hurts everything.

What makes DEKA Research & Development Corp. unique

  • Dean Kamen’s 1982 engineering bench produced LUKE, iBOT, and twiist.
  • DEKA owns core infusion and microneedle IP, not just outsourced design.
  • FDA cleared twiist in 2025, proving repeatable regulated-device execution.

Help us improve and share your feedback! Did you find this helpful?

Company News

Emergex Vaccines Holding Limited
Jan 16th, 2024
Emergex Announces R&D Collaboration with DEKA Research & Development Corp. for Assessment of Emergex's Immunotherapeutic Candidates with DEKA's Intradermal Therapeutic Applicator

- Emergex has entered into an agreement with DEKA Research & Development ('DEKA') to assess the compatibility of Emergex's T cell-priming set-point immunotherapeutic candidates with DEKA's Intradermal Therapeutic Applicator.

Business Wire
Oct 13th, 2022
Revolutionary And Affordable New Robotics System Makes Debut At 2022 First Global Challenge = A Win For Stem Equity

The XRP robot kits can help democratize robotics by getting younger generations excited about STEM and making the field of robotics more affordable and accessible in all parts of the world. The XRP robot kits can help democratize robotics by getting younger generations excited about STEM and making the field of robotics more affordable and accessible in all parts of the world